The National Command and Operation Centre (NCOC) on Tuesday announced that phase III clinical trials for the Covid-19 vaccine will be launched in Pakistan.

The trial is a partnership between the National Institute of Health (NIH) and the CanSinoBio and Beijing Institute of Biotechnology China [BIB].

The trials have begun, said Dr Hasan, an official with the pharmaceutical company.

https://tribune.com.pk/story/2265114/phase-iii-trials-for-chinese-company-cansinobios-covid-19-vaccine-launched-ncoc